All Stories

  1. Postpartum cytokine shifts and IL-10–mediated immune suppression in malaria-infected primigravid women
  2. The clinical significance of monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratios in malaria infection and parasitaemia among pregnant women in Nanoro, Burkina Faso
  3. Postpartum cytokine shifts and IL-10–mediated immune suppression in malaria-infected primigravid women
  4. Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
  5. Development and evaluation of egg yolk-derived antibodies for ELISA diagnostics of African Animal Trypanosomiasis
  6. Effects of gestational age on blood cortisol and prolactin levels during pregnancy in malaria endemic area
  7. Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children
  8. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study
  9. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
  10. Intermediate hepatitis B virus infection prevalence among 1622 pregnant women in rural Burkina Faso and implications for mother-to-child transmission
  11. Immunomodulatory effects of gestational age on blood cortisol and prolactin levels during pregnancy in malaria endemic area
  12. The Public Health Impact and Cost-Effectiveness of the R21/Matrix-M Malaria Vaccine: A Mathematical Modelling Study
  13. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
  14. Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection
  15. Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with increased protection
  16. Altered Ex-Vivo Cytokine Responses in Children With Asymptomatic Plasmodium falciparum Infection in Burkina Faso: An Additional Argument to Treat Asymptomatic Malaria?
  17. Towards environmental Sustainability: Devolving the influence of carbon dioxide emission to population growth, climate change, Forestry, livestock and crops production in Pakistan
  18. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
  19. Evaluating Supplementary Water Methodology with Saturated Soil Irrigation for Yield and Water Productivity Improvement in Semi-Arid Rainfed Rice System, Burkina Faso
  20. Climate disturbance impact assessment in West Africa: evidence from field survey and satellite imagery analysis
  21. Investigating the Influence of International Tourism in Pakistan and Its Linkage to Economic Growth: Evidence From ARDL Approach
  22. Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial
  23. Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
  24. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial
  25. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial
  26. High titres of immunoglobulin g class 1 antibodies to duffy binding-like (DBL) 5 during the third trimester of pregnancy are associated with past placental malaria at delivery in an area of high seasonal transmission in Burkina Faso.
  27. Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso
  28. Poster Sessions
  29. Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites